Author:
Grewal Amandeep S,Nedzelski Julian M,Chen Joseph M,Lin Vincent YW
Abstract
Abstract
Objective
To investigate glucocorticoid uptake in auditory hair cells following transtympanic versus systemic administration of dexamethasone.
Study design
Controlled experimental study.
Setting
Translational science experimental laboratory.
Methods
Swiss-Webster mice were injected with dexamethasone via transtympanic or systemic administration. At 1, 6, or 12 hours post-injection the temporal bones were harvested. After cryosectioning, immunohistochemical staining was performed using an antibody for dexamethasone.
Results
Dexamethasone labelling was greatest at 1 hour. Inner hair cells demonstrated much higher steroid uptake than outer hair cells. Both transtympanic injection and high-dose systemic administration resulted in strong dexamethasone labelling of hair cells, and a decreasing basal-to-apical gradient of hair cell fluorescence intensity was observed. Systemically delivered dexamethasone was rapidly eliminated from the inner ear, demonstrating mild labelling after 6 hours and none after 12 hours. In contrast, the mice receiving transtympanic injection had persistent moderate intensity fluorescence at 6 and 12 hours post-injection.
Conclusion
There is similar uptake of dexamethasone by auditory hair cells after transtympanic and high-dose systemic delivery. Novel findings include the presence of a decreasing basal-apical gradient of steroid uptake, and demonstration of greater affinity of inner hair cells for dexamethasone compared to outer hair cells. In this animal model transtympanic injection resulted in prolonged steroid uptake. These findings help further our understanding of the pharmacokinetics of steroids in the cochlea, with a focus on auditory hair cells.
Publisher
Springer Science and Business Media LLC
Subject
Otorhinolaryngology,Surgery
Reference23 articles.
1. Chen Y, Wen L, Hu P, Qiu J, Lu L, Qiao L: Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy. J Otolaryngol Head Neck Surg. 2010, 39 (6): 640-645.
2. Herr BD, Marzo SJ: Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005, 132: 527-531. 10.1016/j.otohns.2004.09.138.
3. Lee HS, Kim JM, Kim YJ, Chung DH, Seo BS, Kim SH: Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss. J Otolaryngol Head Neck Surg. 2008, 37 (2): 263-268.
4. Plontke SK, Löwenheim H, Mertens J: Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2009, 119: 359-369. 10.1002/lary.20074.
5. Silverstein H, Issacson JE, Olds MJ: Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: A prospective, randomized, double-blind, crossover trial. Am J Otol. 1998, 19: 196-201.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献